Enhanced TCR Transduced Autologous T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enhanced TCR Transduced Autologous T Cells, covering 2018-05-08 to 2018-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma [Phase 1, Phase 2]